Several studies indicate that blockade of the renin-angiotensin-aldosterone system (RAAS) can prevent atherosclerosis and vascular events, but the precise mechanisms involved are still unclear. In this study, we investigated the effect of the AT 1-receptor blocker, candesartan, in the prevention of atherosclerosis in Watanabe heritable hyperlipidaemic (WHHL) rabbits and also the effect of AT1-receptor blockade in the uptake of oxidised LDL by macrophage cell cultures. In the first set of experiments, 12 WHHL rabbits were randomly assigned to three groups: placebo, atenolol 5 mg/kg daily or candesartan 2 mg/kg daily for six months. Compared with controls and atenolol-treated rabbits, candesartan treatment resulted in a significant 50—60% reduction of atherosclerotic plaque formation and a 66% reduction in cholesterol accumulation in the thoracic aorta.
Studies in macrophage cultures indicated that candesartan prevented uptake of oxidised LDL-(oxLDL)-cholesterol by cultured macrophages. Candesartan inhibited the uptake of oxLDL in a dose-dependent manner, reaching a maximum inhibition of 70% at concentrations of 5.6 µg/ml. Further studies in other animal models and well-designed trials in humans are warranted to further explore the role of AT1-receptor blockade in the prevention of atherosclerosis.
Aldeman MH, Madhaven S., Ooi WL, Cohen H., Sealy JE, Laragh JHAssociation of the renin-sodium profile with the risk ofmyocardial infarction in patients with hypertension. N Engl J Med1991;324:1098-104.
2.
Gombien F., Poirier O., Lecerf L. et al. Deletion polymorphism in the gene for angiotensin converting enzyme is a potent risk factor for myocardial infarction. Nature1992;359:641-44.
3.
Rutherford JD , Pfeffer MA, Moye LA et al. Effects of captopril on ischemic events after myocardial infarction: results of the Survival and Ventricular Enlargement Trial: SAVE Investigators, Circulation1994 ;90:1731-8.
4.
Yusuf S., Pepine CJ, Garces C. et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet1992;340:1173-8.
5.
The Heart Outcomes Prevention Evaluation Study (HOPE) Investigators.Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med2000;342:145-3.
6.
Ferrario CM, Deitch JS, Dean RH, Strawn WBHypertension and atherosclerosis: a mechanistic understanding of disease progression . Cardiovasc Risk Factors1996 ;6:299-310.
7.
Clozel M., Kuhn H., Hefti F., Baumgartner HREndothelial dysfunction and subendothelial monocyte macrophages in hypertension .Hypertension1991;18:132-41.
8.
Yanagitani Y. , Rakugi A., Okamura A. et al. Angiotensin II type 1 receptor-mediated peroxide production in human macrophages. Hypertension1999;33(pt II):II-335-9.
9.
Chen XL, Tummala PE, Olbrych MT, Alexander RW, Medford RMAngiotensin II induces monocyte chemoattractant protein-1 gene expresson in rat vascular smooth muscle cells. Circ Res1998;83:952-9.
10.
Tummala PE, Chen XL, Sundell CL et al. Ang II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation1999;100:1223-9.
11.
Rajagopalan S., Kurz S., Munzel T. et al. Ang II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone . J Clin Invest1996;97:1916-23.
12.
Chobanian AV , Haudenschild CC, Nickerson C., Drago R.Anti-atherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit. Hypertension1990;1:327-31.
13.
Chobanian AV , Haudenschild CC, Nickerson C., Hope S.Trandolapril inhibits atherosclerosis in the Watanabe Heritable Hyperlipidemic Rabbit. Hypertension1992;20:473-7.
14.
Schuh JR, Blehmn DJ, Friedrich GE et al. Differential effects of renin-angiotensin blockade on atherogenesis in cholesterol-fed rabbits. J Clin Invest1993;91:1453-8.
15.
Charpiot P. , Rolland P.h, Friggi A. et al. ACE-I with perindopril and atherogenesis-induced structural and functional changes in minipig arteries . Arterioscler Thromb1993;13:1125-38.
16.
Kowala MC, Grove RI,Aberg G.Inhibitors of angiotensin-converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophase-foam cell accumulation independently of BP and plasma lipids. Atherosclerosis1994;108:61-72.
17.
Chobanian AV , Hope S., Brecher P.Dissociation between antiatherosclerotic effect of trandolapril and suppression of serum and aortic angiotensin-converting enzyme activity in the Watanabe Heritable Hyperlipidemic rabbit. Hypertension1995;25:1306-10.
18.
Sugano M., Makino N., Yanaga T.The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits.Atherosclerosis1996;127:123-9.
19.
Hope S., Brecher P., Chobanian AVComparison of the effects of AT1 receptor blockade and angiotensin converting enzyme inhibition on atherosclerosis.AmJHypertens1999;12:28-34.
20.
Allain CA, Poon LS, Chan CSG, Richmond W., Fu PCEnzymatic determination of total serum cholesterol. Clin Chem1974;20:470-3.
21.
Basu SK, Brown MS, Ho YK, Havel RJ, Goldstein JLMouse macrophages synthesize and secrete a protein resembling apolipoprotein E. Proc Nat Acad Sci1981;78:7545-9.
22.
Esterbauer H., Striegl G., Puhl H., Rothhender M.Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comms1989;6:67-75.
23.
Van Niekerk JLM , Hendriks T., Deboer HHM, Van't Laar A.Does nifedipine suppress atherogenesis in WHHL rabbits: Atherosclerosis1984:53:91-8.
24.
Tilton GD, Buja LM, Bilheimer DW et al. Failure of a slow channel calcium antagonist, verapamil, to retard atherosclerosis in the Watanbe heritable hyperlipidemic rabbit: an animal model of familial hypercholsterolemia. J Am Coll Cardiol1985;6:141-4.
25.
Lichtenstein AH, Drago R., Nickerson C. et al.The effect of propranolol on atherogenesis in the Watanabe heritable hyperlipidemic rabbit .JVasc Med Biol1989;1:248-54.
26.
Strawn WB, Chappell MC, Dean RH, Kivlighn S., Ferrario CMInhibition of early atherogenesis by losartan in monkeys with diet-induced hypercholesterolaemia. Circulation2000;101:1586-93.
27.
Stary HC, Chandler AB, Glagov S. et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis. American Heart Association. Arterioscler Thromb1994;14:840-56.
28.
Li DY, Zhang YC, Philips MI, Sawamura T., Mehta JLUpregulation of endothelial receptor for oxidised low-density liproprotein (LOX-1) in cultured human coronary artery endothelial cells by Ang II type 1 receptor activation. Cir Res1999;84:1043-49.
